Malaysia vs Papua New Guinea: Reported cases of paralytic polio
Malaysia
0 cases
in 2023
Papua New Guinea
0 cases
in 2023
Malaysia rank
26th
Papua New Guinea rank
26th
Reported cases of paralytic polio over time
- Malaysia
- Papua New Guinea
How they compare
Malaysia currently reports 0 cases against 0 cases in Papua New Guinea, a difference of 0 cases.
The two have swapped places 6 times across 44 shared years of data; in 1980 it was Papua New Guinea ahead.
Malaysia ranks 26th and Papua New Guinea ranks 26th of 199 countries.
Across the 5 decades both report, Malaysia averaged higher in 1 and Papua New Guinea in 3.
Head to head by decade
| Decade | Malaysia | Papua New Guinea | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 2.1 cases | 15.6 cases | 13.5 cases | Papua New Guinea |
| 1990s | 0.6 cases | 1.1 cases | 0.5 cases | Papua New Guinea |
| 2000s | 0 cases | 0 cases | 0 cases | — |
| 2010s | 0.3 cases | 2.6 cases | 2.3 cases | Papua New Guinea |
| 2020s | 0.25 cases | 0 cases | 0.25 cases | Malaysia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported cases of paralytic polio, Malaysia or Papua New Guinea?
- Malaysia, at 0 cases against 0 cases in Papua New Guinea as of 2023.
- What is the difference in reported cases of paralytic polio between Malaysia and Papua New Guinea?
- 0 cases, with Malaysia ahead.
- How many years of comparable data are there for Malaysia and Papua New Guinea?
- 44 years are reported by both, from 1980 to 2023.
- How do Malaysia and Papua New Guinea rank globally for reported cases of paralytic polio?
- Malaysia ranks 26th and Papua New Guinea ranks 26th of 199 countries.
- Where does this data come from?
- World Health Organization (2019); World Health Organization (2024) – processed by Our World in Data, published as Reported cases of paralytic polio. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Sum of wild poliovirus cases and circulating vaccine derived poliovirus cases.